Primary Open Angle African-American Glaucoma Genetics Study Renewal
Primary Open Angle African-American Glaucoma Genetics Study Renewal
批准号:
10668949
负责人:
JOAN M O'BRIEN
金额:
$142.03万
依托单位国家:
美国
项目类别:
财政年份:
2014
资助国家:
美国
项目状态:
未结题
起止时间:
2014-04-01 至 2026-03-31
关键词:
AddressAffectAfrican AmericanAfrican American populationAfrican ancestryAgeAmericanAuthorization documentationBilateralBiologicalBiological ModelsBlindnessCRISPR/Cas technologyCell Culture TechniquesCell modelCellsCitiesClinicalCodeCohort StudiesDNA sequencingDataDevelopmentDiseaseDisparityElectrophysiology (science)EnhancersEthnic PopulationEuropeanFamilial diseaseFundingGenerationsGenesGeneticGenetic Predisposition to DiseaseGenetic VariationGenetic studyGenomicsGenotypeGlaucomaGoalsHealthIndividualInterventionLentivirus VectorMeta-AnalysisModelingMorphologyPathway interactionsPatientsPersonsPhasePhenotypePhiladelphiaPopulationPrecision therapeuticsPredispositionPrevalencePrimary Open Angle GlaucomaPublic HealthRecontactsRetinal Ganglion CellsRiskRoleSNP arraySpecialistStructureSusceptibility GeneSymptomsTarget PopulationsTestingTherapeutic InterventionTrabecular meshwork structureUntranslated RNAVariantVisual impairmentblindburden of illnesscausal variantcohorteconomic outcomeendophenotypeexomeexome sequencingexperiencegene functiongenetic informationgenetic variantgenome editinggenome wide association studygenome-widegenome-wide analysisgenomic datahuman datainduced pluripotent stem cellinterestloss of functionnoveloptic nerve disorderoverexpressionphenotypic datapolygenic risk scorepressurepromoterrare variantrecruitscreeningstructural genomicssuccesstraittranscriptometranscriptome sequencing
中文摘要
简要说明
原发性开角型青光眼(POAG)是一个紧迫的公共卫生问题,
非裔美国人这种疾病是导致这些人不可逆失明的主要原因。
个体开角型青光眼在早期对非裔美国人的影响更严重,
年轻一代视力丧失,健康和经济状况不佳。
目前对这种疾病的降压治疗取得了好坏参半的成功,
大约30%的患者仍在经历视力丧失。POAG是一种家族性疾病
并且需要大规模的遗传学研究来阐明疾病机制。这
非洲裔美国人的需求尤其明显,尽管他们的需求增加,
疾病负担,仍然严重不足。在最初的筹资阶段,
原发性开角型非裔美国人青光眼遗传学(POAAGG)研究
通过对非洲裔美国人进行有史以来最大规模的POAG遗传学研究,
从一个城市招募为了这次更新,我们将研究来自基因组的遗传数据-
7765名受试者的广泛关联研究和8082名受试者的全外显子组测序,
以及>90%的POAG病例的丰富表型数据。拟议的更新将
使我们能够进一步研究和识别对非洲人具有生物重要性的变异,
美国POAG本研究的目的是:1)对GWAS后的
POAAGG研究中的全基因组显著变异,以阐明它们在这一过程中的作用。
疾病,2)通过以下方法确定非洲裔美国人POAG的其他感兴趣区域:
全外显子组和结构基因组学分析,和3)评估功能
细胞模型系统中感兴趣区域的影响。我们的发现将开始定义
非洲裔美国人POAG的相关生物学途径,这可能提供
用于人群筛查和精确治疗的靶点。
英文摘要
Summary Statement
Primary open-angle glaucoma (POAG) represents a pressing public health problem in
African Americans. This disease is the leading cause of irreversible blindness in these
individuals. POAG affects African Americans more severely at earlier ages, contributing
to younger generations with vision loss and adverse health and economic outcomes.
Current pressure-lowering treatments for the disease have mixed success, with
approximately 30% of patients still experiencing vision loss. POAG is a familial disease
and there is a need for large genetic studies that elucidate disease mechanisms. This
need is especially pronounced in African Americans, who, despite their increased
burden of disease, remain seriously understudied. In its initial funding phase, the
Primary Open-Angle African American Glaucoma Genetics (POAAGG) study addressed
this disparity by conducting the largest-ever POAG genetics study on African Americans
recruited from a single city. For this renewal, we will study genetic data from a genome-
wide association study of 7765 subjects and whole-exome sequencing of 8082 subjects,
as well as rich phenotypic data on >90% of POAG cases. The proposed renewal will
allow us to further investigate and identify variants of biologic importance to African
American POAG. The aims of this study are: 1) to conduct post-GWAS analyses on
genome-wide significant variants from the POAAGG study to elucidate their role in this
disease, 2) to identify additional regions of interest for African American POAG through
whole-exome and structural genomics analyses, and 3) to evaluate the functional
impact of regions of interest in cellular model systems. Our findings will begin to define
relevant biologic pathways for African American POAG, which can potentially provide
targets for population screening and precision therapeutics.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Primary Open Angle African-American Glaucoma Genetics Study Renewal
-
批准号:10400065
-
项目类别:
-
资助金额:$165.32万
-
财政年份:2014
-
负责人:JOAN M O'BRIEN
-
依托单位:
Primary Open Angle African-American Glaucoma Genetics (POAAGG)
-
批准号:8560079
-
项目类别:
-
资助金额:$226.38万
-
财政年份:2014
-
负责人:JOAN M O'BRIEN
-
依托单位:
Primary Open Angle African-American Glaucoma Genetics (POAAGG)
-
批准号:8815318
-
项目类别:
-
资助金额:$221.32万
-
财政年份:2014
-
负责人:JOAN M O'BRIEN
-
依托单位:
Improved Ophthalmic Care for Retinoblastoma Patients
-
批准号:6641270
-
项目类别:
-
资助金额:$34.09万
-
财政年份:2002
-
负责人:JOAN M O'BRIEN
-
依托单位:
Improved Ophthalmic Care for Retinoblastoma Patients
-
批准号:6910647
-
项目类别:
-
资助金额:$34.09万
-
财政年份:2002
-
负责人:JOAN M O'BRIEN
-
依托单位:
Improved Ophthalmic Care for Retinoblastoma Patients
-
批准号:7123301
-
项目类别:
-
资助金额:$21.9万
-
财政年份:2002
-
负责人:JOAN M O'BRIEN
-
依托单位:
Improved Ophthalmic Care for Retinoblastoma Patients
-
批准号:7250161
-
项目类别:
-
资助金额:$29.39万
-
财政年份:2002
-
负责人:JOAN M O'BRIEN
-
依托单位:
Improved Ophthalmic Care for Retinoblastoma Patients
-
批准号:7082066
-
项目类别:
-
资助金额:$62.64万
-
财政年份:2002
-
负责人:JOAN M O'BRIEN
-
依托单位:
Improved Ophthalmic Care for Retinoblastoma Patients
-
批准号:6544745
-
项目类别:
-
资助金额:$33.86万
-
财政年份:2002
-
负责人:JOAN M O'BRIEN
-
依托单位:
Improved Ophthalmic Care for Retinoblastoma Patients
-
批准号:6765946
-
项目类别:
-
资助金额:$34.09万
-
财政年份:2002
-
负责人:JOAN M O'BRIEN
-
依托单位:
海外基金